Dominari HoldingsDOMH
DOMH
About: Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.
Employees: 28
0
Funds holding %
of 6,740 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
600% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 1
0.85% less ownership
Funds ownership: 8.61% [Q1] → 7.76% (-0.85%) [Q2]
24% less funds holding
Funds holding: 17 [Q1] → 13 (-4) [Q2]
24% less capital invested
Capital invested by funds: $1.13M [Q1] → $862K (-$267K) [Q2]
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Research analyst outlook
We haven’t received any recent analyst ratings for DOMH.
Financial journalist opinion
Charts implemented using Lightweight Charts™